NovoLog PenFill and Onasemnogene Abeparvovcec Infusion
Determining the interaction of NovoLog PenFill and Onasemnogene Abeparvovcec Infusion and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma), Onasemnogene Abeparvovec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog PenFill-Onasemnogene Abeparvovec
- NovoLog PenFill-Onasemnogene abeparvovec Zolgensma
- NovoLog PenFill-Oncaspar
- NovoLog PenFill-Oncovin
- NovoLog PenFill-Ondansetron
- NovoLog PenFill-Ondansetron and Dextrose
- Onasemnogene Abeparvovcec Infusion-Novoseven
- Onasemnogene Abeparvovcec Infusion-NovoSeven RT
- Onasemnogene Abeparvovcec Infusion-NovoSeven RT with MixPro injection
- Onasemnogene Abeparvovcec Infusion-Novothyrox
- Onasemnogene Abeparvovcec Infusion-Noxafil
- Onasemnogene Abeparvovcec Infusion-Noxafil (Posaconazole Delayed-Release Tablets)